The development of nanocarriers for the diagnosis and treatment of cancer is driven by principles from many fields of science. The various sizes, materials, and targeting moieties of nano-scale platforms introduce the possibility of targeting both tumors and individual cancer cells. This review focuses on the emerging implications of targeted nanocarriers for cancer therapeutics. The vibrant activity in this field is demonstrated by the large number of studies using various delivery platforms and the promising results from clinical trials. Nano-scale carriers are already having a profound impact on cancer research and therapies and will likely play an increasing role in the treatment of cancer in the near future. In this presentation, I will give specific examples on how the engineering of safe nanoparticles can be utilized for personalized therapeutic intervention in ovarian cancer, glioblastoma multiforme and different types of blood cancers.
